Abstract
Rats were administered fenfluramine (FF: 3 mg/kg) or fluoxetine (FX: 6 mg/kg) daily for 3 weeks. On acute administration, FF suppressed consumption of 35% sucrose (in a 40 min test) and overnight chow intake. Repeated administration saw the rapid development of extensive tolerance to these effects. FF had no effects on body weight, and no withdrawal effects were apparent. FX reduced chow intake and body weight throughout the treatment period, but there was evidence of some tolerance to the suppression of chow intake and sucrose drinking. Following FX withdrawal, normal body weight was restored in 4 days; food intake was normal during this period. A delayed rebound hyperphagia commenced on day 5 of withdrawal, and persisted for at least 6 days. The behavioural satiety sequence (drinking -activity - grooming - resting) was disrupted by acute FF; on chronic treatment, FF advanced the onset of postprandial resting, but also increased drinking time. FX advanced the behavioural satiety sequence on acute administration, but not after chronic treatment. We consider the implications of these results for the use of resting behaviour as an indicator of postprandial satiety.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angel I, Taranger M-A, Claustre Y, Scatton B, Langer SZ (1988) Anorectic activities of serotonin uptake inhibitors: Correlation with their potencies at inhibiting serotonin uptake in vivo and3H-mazindol binding in vitro. Life Sci 43:651–658
Antin J, Gibbs J, Holt J, Young RC, Smith GP (1975) Cholecystokinin elicits the complete behavioural sequence of satiety in rats. Physiol Psychol 89:784–790
Blundell JE (1986) Serotonin manipulations and the structure of feeding behaviour. Appetite 7[suppl]:39–56
Burton MJ, Cooper SJ, Popplewell DA (1981) The effect of fenfluramine on the microstructure of feeding and drinking in the rat. Br J Pharmacol 72:621–633
Caccia S, Cappi M, Fracasso C, Garattini S (1990) Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100:509–514
Clifton PG, Barnfield AMC, Philcox L (1989) A behavioural profile of fluoxetine-induced anorexia. Psychopharmacology 97:89–95
Cooper SJ, Francis RL (1979) Feeding parameters with two food textures after chlordiazepoxide administration, alone or in combination withd-amphetamine or fenfluramine. Psychopharmacology 62:253–259
Foltin RW, Fischman MW (1988) Food intake in baboons: effects ofd-amphetamine and fenfluramine. Pharmacol Biochem Behav 31:585–592
Fuller RW, Wong DT (1977) Inhibition of serotonin uptake. Fed Proc 36:2154–2158
Fuller RW, Snoddy HD, Robertson DW (1988) Mechanisms of effects ofd-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol Biochem Behav 30:715–721
Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R (1986) Neurochemical mechanism of action of drugs which modify feeding via the serotonergic system. Appetite 7 [suppl]:15–38
Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebre P, Turner P (1989) International trial of long-term dexfenfluramine in obesity. Lancet ii:1142–1145
Hudson KD (1977) The anorectic and hypotensive effect of fenfluramine in obesity. J R Coll Gen Pract 27:497
Hutson PH, Donohoe TP, Curzon G (1988) Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95:550–552
Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a post-synaptic site. Eur J Pharmacol 141:429–435
Kinney-Parker J, Smith D, Ingle SF (1989) Fluoxetine and weight: something lost and something gained? Clin Pharm 8:727–733
Kushner LR, Mook DG (1984) Behavioural correlates of oral and post-ingestive satiety in the rat. Physiol Behav 33:713–718
Leander JD (1987) Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology 91:285–287
Levine LR, Rosenblatt S, Bosomworth J (1987) Use of a serotonin reuptake inhibitor, fluoxetine, in the treatment of obesity. Int J Obes 11 [suppl 3]:185–190
Lucki I, Kreider MS, Simansky KJ (1988) Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline. Psychopharmacology 96:289–295
McGuirk J, Silverstone T (1990) The effect of the 5-HT reuptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 14:361–372
McGuirk J, Goodall E, Silverstone T, Willner P (1991a) Differential effects ofd-fenfluramine,l-fenfluramine andd-amphetamine on the microstructure of human eating behaviour. Behav Pharmacol 2:113–119
McGuirk J, Muscat R, Willner P (1991b) Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A/B agonist, eltoprazine, on the behavioural safety sequence. Pharmacol Biochem Behav (in press)
Mennini T, De Blasi A, Borroni E, Bendotti C, Borsini F, Samanin R, Garattini S (1981) Biochemical and functional studies on tolerance to anorectic activity ofd-fenfluramine in comparison withd-amphetamine. In: Garattini S, Samanin R (eds) Anorectic agents: mechanisms of action and tolerance. Raven Press, New York, pp 87–100
Monro JF, Ford MJ (1982) Drug treatment of obesity. In: Silverstone T (ed) Drugs and appetite. Academic Press, London, pp 125–157
Montgomery AMJ, Willner P (1988) Fenfluramine disrupts the behavioural satiety sequence in rats. Psychopharmacology 94:397–401
Morley JE, Flood JF (1987) An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice. Life Sci 41:2157–2165
Neill JC, Cooper SJ (1989) Evidence thatd-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 97:213–218
Pinder RM, Brogden RN, Gawyer RR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and its therapeutic efficacy in obesity. Drugs 10:241–323
Rowland NE (1986) Effect of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats. Life Sci 39:2581–2586
Rowland NE, Carlton J (1986) Tolerance to fenfluramine anorexia: fact or fiction? Appetite 7 [suppl]:71–83
Rowland NE, Antelman SM, Kocan D (1982) Differences among “serotonergic” anorectics in a cross-tolerance paradigm: do they all act on serotonin systems? Eur J Pharmacol 81:57–66
Samanin R, Mennini T, Bendotti C, Barone D, Caccia S, Garattini S (1989) Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity ofd-fenfluramine in the rat. Neuropharmacology 28:465–469
Smith GP, Gibbs J (1975) Postprandial satiety. In: Sprague JM, Epstein AN (eds) Progress in psychobiology and physiological psychology, vol 8. Academic Press, New York, pp 180–242
Willner P (1989) Sensitization to the effects of antidepressant drugs. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: tolerance and sensitization. Humana, Clifton, pp 407–459
Willner P, McGuirk J, Phillips G, Muscat R (1990) Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology 102:273–277
Wong DT, Reid LR, Bymaster FP, Threlkeld PG (1985) Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm 64:251–269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGuirk, J., Muscat, R. & Willner, P. Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology 106, 401–407 (1992). https://doi.org/10.1007/BF02245426
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245426